How to buy IDEXX Laboratories stock

IDEXX Laboratories, Inc is a diagnostics & research business based in the US. IDEXX Laboratories shares (IDXX) are listed on the NASDAQ and all prices are listed in US Dollars. IDEXX Laboratories employs 9,200 staff and has a trailing 12-month revenue of around USD$2.6 billion.

How to buy shares in IDEXX Laboratories

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for IDEXX Laboratories. Find the stock by name or ticker symbol: IDXX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until IDEXX Laboratories reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of IDEXX Laboratories, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of IDEXX Laboratories. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

IDEXX Laboratories share price

Use our graph to track the performance of IDXX stocks over time.

IDEXX Laboratories shares at a glance

• Key figures

Information last updated 2021-01-24.

52-week range	USD$168.65 - USD$516.87
50-day moving average	USD$484.4355
200-day moving average	USD$418.8379
Wall St. target price	USD$500.6
PE ratio	85.924
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$5.736

Buy IDEXX Laboratories shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy IDEXX Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of IDEXX Laboratories, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is IDEXX Laboratories under- or over-valued?

Valuing IDEXX Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IDEXX Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

IDEXX Laboratories's P/E ratio

IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 86x. In other words, IDEXX Laboratories shares trade at around 86x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

IDEXX Laboratories's PEG ratio

IDEXX Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.9832. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IDEXX Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

IDEXX Laboratories's EBITDA

IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$732.5 million.

The EBITDA is a measure of a IDEXX Laboratories's overall financial performance and is widely used to measure a its profitability.

IDEXX Laboratories financials

Revenue TTM	USD$2.6 billion
Operating margin TTM	24.64%
Gross profit TTM	USD$1.4 billion
Return on assets TTM	21.01%
Return on equity TTM	154.61%
Profit margin	19.2%
Book value	$5.165
Market capitalisation	USD$42 billion

TTM: trailing 12 months

Shorting IDEXX Laboratories shares

There are currently 773,211 IDEXX Laboratories shares held short by investors – that's known as IDEXX Laboratories's "short interest". This figure is 13% up from 684,533 last month.

There are a few different ways that this level of interest in shorting IDEXX Laboratories shares can be evaluated.

IDEXX Laboratories's "short interest ratio" (SIR)

IDEXX Laboratories's "short interest ratio" (SIR) is the quantity of IDEXX Laboratories shares currently shorted divided by the average quantity of IDEXX Laboratories shares traded daily (recently around 373531.88405797). IDEXX Laboratories's SIR currently stands at 2.07. In other words for every 100,000 IDEXX Laboratories shares traded daily on the market, roughly 2070 shares are currently held short.

However IDEXX Laboratories's short interest can also be evaluated against the total number of IDEXX Laboratories shares, or, against the total number of tradable IDEXX Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IDEXX Laboratories's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 IDEXX Laboratories shares in existence, roughly 10 shares are currently held short) or 0.0103% of the tradable shares (for every 100,000 tradable IDEXX Laboratories shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IDEXX Laboratories.

Find out more about how you can short IDEXX Laboratories stock.

IDEXX Laboratories's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like IDEXX Laboratories.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

IDEXX Laboratories's total ESG risk score

Total ESG risk: 29.79

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and IDEXX Laboratories's overall score of 29.79 (as at 01/01/2019) is nothing to write home about – landing it in it in the 55th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like IDEXX Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

IDEXX Laboratories's environmental score

Environmental score: 9.93/100

IDEXX Laboratories's environmental score of 9.93 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

IDEXX Laboratories's social score

Social score: 14.44/100

IDEXX Laboratories's social score of 14.44 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

IDEXX Laboratories's governance score

Governance score: 17.91/100

IDEXX Laboratories's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that IDEXX Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

IDEXX Laboratories, Inc was last rated for ESG on: 2019-01-01.

Total ESG score	29.79
Total ESG percentile	54.84
Environmental score	9.93
Environmental score percentile	6
Social score	14.44
Social score percentile	6
Governance score	17.91
Governance score percentile	6

IDEXX Laboratories share dividends

We're not expecting IDEXX Laboratories to pay a dividend over the next 12 months.

Have IDEXX Laboratories's shares ever split?

IDEXX Laboratories's shares were split on a 2:1 basis on 16 June 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your IDEXX Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for IDEXX Laboratories shares which in turn could have impacted IDEXX Laboratories's share price.

IDEXX Laboratories share price volatility

Over the last 12 months, IDEXX Laboratories's shares have ranged in value from as little as $168.65 up to $516.87. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IDEXX Laboratories's is 0.8797. This would suggest that IDEXX Laboratories's shares are less volatile than average (for this exchange).

IDEXX Laboratories overview

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Frequently asked questions

• What percentage of IDEXX Laboratories is owned by insiders or institutions?

  Currently 1.049% of IDEXX Laboratories shares are held by insiders and 88.366% by institutions.

• How many people work for IDEXX Laboratories?

  Latest data suggests 9,200 work at IDEXX Laboratories.

• When does the fiscal year end for IDEXX Laboratories?

  IDEXX Laboratories's fiscal year ends in December.

• Where is IDEXX Laboratories based?

  IDEXX Laboratories's address is: One IDEXX Drive, Westbrook, ME, United States, 04092

• What is IDEXX Laboratories's ISIN number?

  IDEXX Laboratories's international securities identification number is: US45168D1046

• What is IDEXX Laboratories's CUSIP number?

  IDEXX Laboratories's Committee on Uniform Securities Identification Procedures number is: 45168D104